Small molecule PDE4 inhibitors with broad spectrum anti-inflammatory effects have been shown to reduce inflammatory cell recruitment and improve lung function in animal models of COPD [21-23]. The gene discussed is PDE4A; the disease is chronic obstructive pulmonary disease.